The 1 analysts offering 12-month price forecasts for Diffusion Pharmaceuticals Inc have a median target of 100.00, with a high estimate of 100.00 and a low estimate of 100.00. The median estimate represents a +1,165.82% increase from the last price of 7.90.
The current consensus among 1 polled investment analysts is to Hold stock in Diffusion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.77
Reporting Date Aug 15
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.